Riabni Prices, Coupons and Patient Assistance Programs
Riabni (rituximab) is a member of the CD20 monoclonal antibodies drug class and is commonly used for Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and others.
Riabni Prices
The cost for Riabni intravenous solution (arrx 10 mg/mL) is around $758 for a supply of 10 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
This Riabni price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Intravenous Solution
| Quantity | Per unit | Price |
|---|---|---|
| 10 milliliters | $75.78 | $757.84 |
| 50 milliliters | $75.02 | $3,751.20 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardPlease note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Riabni Coupons and Rebates
Riabni offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Riabni Amgen First Step Program: Eligible commercially insured patients may pay only $5 per dose/cycle with savings of up to the program maximum per calendar year; $0 co-pay on 1st dose/cycle; for additional information contact the program at 888-657-8371.
| Applies to: | Riabni |
| Number of uses: | per prescription per calendar year |
Riabni Amgen First Step Program Rebate: Eligible commercially insured patients who have already paid for treatment may request a rebate check; for additional information contact the program at 888-657-8371.
| Applies to: | Riabni |
| Number of uses: | One rebate per prescription fill |
Patient Assistance Programs for Riabni
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
- Riabni (rituximab-ARRX) Injection; IV
Provider: Amgen FIRST STEP Co-Pay Support
Elligibility requirements:- May have private/commercial insurance coverage (not a participant in federal or state-funded benefits program)
- Not Required
- Medically appropriate condition/diagnosis
- The patient must also be a US citizen.
- Health Care Providers must enroll in the program prior to processing the Amgen FIRST STEP Program Cards
Applicable drugs:
- Riabni (rituximab-ARRX) Injection; IV
More about Riabni (rituximab)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- En Español
- Drug class: CD20 monoclonal antibodies
- FDA Alerts (1)
- FDA Approval History
